{
  "id": 20911382,
  "title": "STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive",
  "url": "https://urgent.news/2026/11/20/stat-early-results-for-alteromes-kras-drug-for-pancreas-lung-and",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-20T14:01:41.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/11/20/biotech-news-early-results-for-alterome-kras-drug-arrive/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Alterome presented preliminary Phase 1 results of its drug “selectively” targeting a range of KRAS mutations — drivers of cancers in the pancreas, lung and colon:",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}